Risk factors associated with response to highly active antiretroviral therapy after 24 months of administration to HIV, HIV/HBV and HCV patients in Kumba Health District, South West Region of Cameroon
<p>Hepatitis B (HBV) and C (HCV) are two other forms of infections for which co-infection in HIV has been associated with alteration of the immune response, increased risk of progression to liver diseases, and increased risk of hepatotoxicity associated with antiretroviral therapy. This study...
Saved in:
Main Authors: | Adamu Ndongho Ndifontiayong (Author), Innocent Mbulli Ali (Author), Jean Baptiste Sokoudjou (Author), Karimo Ousenu (Author), Jerimiah Ndimumeh Mbogwe (Author), Ousenu Karimo (Author), Christopher Bonglavnyuy Tume (Author) |
---|---|
Format: | Book |
Published: |
Archives of Clinical Gastroenterology - Peertechz Publications,
2022-09-26.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of malaria parasitemia in people living with HIV/AIDS in Kumba, Cameroon
by: Eyong Clinton Achere, et al.
Published: (2022) -
Sero-prevalence of Hepatitis B and C virus and High Risk of Hepatotoxicity among TB/HIV Positive and HIV Negative Population in Western Cameroon
by: Leonard Fonkeng Sama, et al.
Published: (2017) -
Heme and HO-1 inhibition of HCV, HBV, and HIV
by: Warren N Schmidt, et al.
Published: (2012) -
Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana
by: Arora Dimple, et al.
Published: (2010) -
Acceptability and Feasibility of the Plasma Separation Card for an Integrated Model of Care for HBV and HCV Screening Among People Attending HIV Clinics in Cameroon and Uganda
by: Camila A Picchio, et al.
Published: (2024)